CJA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Résumé de cet Article
Right arrow Full Text (PDF)
Right arrow Submit a scholarly reply
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yamaguchi, S.
Right arrow Articles by Kitajima, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yamaguchi, S.
Right arrow Articles by Kitajima, T.
Canadian Journal of Anesthesia 48:34-37 (2001)
© Canadian Anesthesiologists' Society, 2001

General Anesthesia

High concentration sevoflurane induction of anesthesia accelerates onset of vecuronium neuromuscular blockade

Shigeki Yamaguchi, MD PhD, Hirotoshi Egawa, MD, Keiko Okuda, MD, Mutsuo Mishio, MD PhD, Yasuhisa Okuda, MD PhD and Toshimitsu Kitajima, MD PhD

From the Department of Anesthesiology, Dokkyo University School of Medicine, Mibu, Tochigi 321-0293, Japan.

Address correspondence to: Shigeki Yamaguchi MD PhD. Phone: 81-282-861111; Fax: 81-282-860478; E-mail: sigeki{at}peach.ocn.ne.jp


    Abstract
 TOP
 Abstract
 Methods
 Results
 Discussion
 References
 
Purpose: To investigate neuromuscular block using accelography after administration of vecuronium under sevoflurane 8% induction and maintenance with sevoflurane 2% in adults.

Methods: Patients were allocated to three groups: (1) group I: anesthesia was induced and maintained with propofol and fentanyl (n=15), (2) group II: anesthesia was induced with propofol and maintained with N2O(66%)-O2-sevoflurane 2% (n=15), (3) group III: anesthesia was induced with sevoflurane 8% using a vital capacity inhalation induction and maintained with N2O(66%)-O2-sevoflurane 2% (n=15). 0.1 mg•kg–1 vecuronium was used for paralysis three minutes after anesthetic induction and reversed using intravenous 0.04 mg•kg–1 neostigmine with 0.02 mg•kg–1 atropine when the train-of-four (TOF) ratio returned to 25%.

Results: The onset time from initial administration of vecuronium to maximal block in the group III was shorter than that in the groups I and II (139 ± 35, 193 ± 35 and 188 ± 47s, respectively: P < 0.05). The clinical duration from maximal block to 25% recovery of TOF ratio in group II and III was longer than that in the group I (47 ± 15, 48 ± 14 and 36 ± 10 min, respectively: P < 0.05). The reversal times from administration of neostigmine to 75% of TOF ratio in groups II and III were longer than that in the group I (196 ± 53, 208 ± 64 and 136 ± 28s, respectively: P < 0.05).

Conclusions: Vital capacity inhalation induction of anesthesia with sevoflurane accelerates onset and prolongs duration of vecuronium neuromuscular block compared with propofol-fentanyl anesthesia.

VITAL capacity inhalation with a high concentration of sevoflurane has been described for the rapid induction of anesthesia.1,2 A vital capacity induction technique with approximately 8% sevoflurane provides more rapid induction and reduced side effects compared with other intravenous or inhaled anesthetics.15

Since sevoflurane increases both intensity and duration of a non-depolarizing muscle relaxant,68 anesthetic induction with a high concentration of sevoflurane followed by maintenance with sevoflurane may induce a more rapid onset time and longer duration of action of non-depolarizing muscle relaxants.

The purpose of this study was to clarify the onset and duration of action of vecuronium after a high concentration sevoflurane induction of anesthesia using the vital capacity induction technique compared with the conventional techniques using propofol or propofol-sevoflurane anesthesia.


    Methods
 TOP
 Abstract
 Methods
 Results
 Discussion
 References
 
After obtaining approval of the hospital ethics committee and informed consent, 45 patients, aged 30-59 yr old, ASA 1 or 2, scheduled for elective surgery were studied. The surgical procedures were otorhinolaryngologic, oral or orthopedic and involved minimal blood loss. Patients were within 15% of ideal body weight and those with hepatic, renal or neuromuscular disease were excluded. In addition, none had received any medication that might potentiate the action of neuromuscular blocking drugs. The study was randomized and double-blind. Observations were made by a single-blinded anesthesiologist and induction of anesthesia was performed by an anesthesiologist familiar with the vital capacity induction technique.

Patients were premedicated with 0.5 mg atropine and 50 mg hydroxyzine one hour before surgery. After arriving in the operating room, the cutaneous electrodes of an accelerograph (TOF-Guard®, Organon Teknika B.V., Netherlands) were applied to the right wrist and the acceleration transducer was fastened to the right thumb. Venous cannulation was performed on the dorsum of the left hand. Indirect arterial blood pressure and pulse oximetry were monitored in the left arm. Electrocardiography, capnography and rectal temperature were also used as monitors.

Patients were randomly allocated to three groups (Table IGo). In the propofol-sevoflurane and sevoflurane 8% groups, the circle system of the anesthetic machine (A-VSEVO; Aladin Cassette for Sevoflurane with Quik FilTM, Datex-Omeda, Sweden) was primed for five minutes with sevoflurane 2 or 8% in oxygen mixture at 6 l•min–1 fresh gas flow, respectively.


View this table:
[in this window]
[in a new window]
 
TABLE I Methods of anesthetic induction and maintenance in three groups
 
In the propofol and propofol-sevoflurane groups, anesthesia was induced by intravenous injection of propofol and standard controlled ventilation was performed with a face mask in oxygen 100%. In the sevoflurane 8% group, patients were breathing room air before induction of anesthesia. They were instructed to breathe out to residual volume and then the face mask was fitted tightly. They took a vital capacity breath of sevoflurane 8% in oxygen 100% which they held as long as possible.3 When they could no longer hold their breath, they were allowed to breathe normally. After loss of consciousness, assisted ventilation was started with a face mask, and then we performed standard controlled ventilation after breathing stopped.

The ulnar nerve was stimulated at a frequency of 2 Hz in trains lasting two seconds every 15 sec. The train-of four (TOF) stimulus was used to give single twitch height. The accelerograph was adjusted to supramaximal stimulation and the baseline response was obtained three minutes after the start of anesthetic induction in the three groups. Immediately after obtaining the baseline value, 0.1 mg•kg–1 vecuronium was administered intravenously in all groups. Ventilation was controlled after tracheal intubation, and PETCO2 was maintained between 35 to 40 mmHg during the study.

Neuromuscular block was reversed using 0.04 mg•kg–1 neostigmine with 0.02 mg•kg–1 atropine when the TOF ratio had returned to 25%.

Measurements were made of (1) onset time (T0) from initial administration of vecuronium to maximal block, (2) clinical duration (T25) from maximal block to 25% recovery of the twitch height, and (3) reversal time (TOF25–75) from the administration of neostigmine to 75% of the TOF ratio.

Data were expressed as mean ± SD. Statistical analysis of the data was performed using one-way ANOVA, followed by Bonferroni correction. Statistical significance was assumed at P < 0.05.


    Results
 TOP
 Abstract
 Methods
 Results
 Discussion
 References
 
No demographic differences were found among the three groups (Table IIGo). No patient experienced hypothermia during anesthesia.


View this table:
[in this window]
[in a new window]
 
TABLE II Demographic data.
 
Onset time in the sevoflurane 8% group was shorter than in the other groups. There was no difference between the propofol and propofol-sevoflurane groups. Clinical duration and reversal time in both sevoflurane 8% and propofol-sevoflurane groups were longer than those in the propofol group (Table IIIGo).


View this table:
[in this window]
[in a new window]
 
TABLE III Neuromuscular measurement
 

    Discussion
 TOP
 Abstract
 Methods
 Results
 Discussion
 References
 
A high concentration of sevoflurane is the most suitable for inhalation induction.3,911 A vital capacity induction technique with high concentration of sevoflurane produces a more rapid induction, reduced adverse airway events and decrease of cardiovascular instability than conventional inhalation induction technique with gradual increases of the concentration.11 We used sevoflurane 8% concentration as an inhalation induction according to Hall et al.1 They showed that the times to loss of eyelash reflex and jaw relaxation under 8% sevoflurane in 100% oxygen were 71 sec and 169 sec, respectively.1 Therefore, vecuronium was administered three minutes after inhalation induction of sevoflurane 8% in oxygen 100% and the onset time of vecuronium neuromuscular block was accelerated compared with conventional induction techniques using propofol-fentanyl or propofol-sevoflurane anesthesia in the present study. A vital capacity induction technique with a high concentration of sevoflurane may produce conditions for tracheal intubation rapidly. Our results may be added to highlight the advantages of vital capacity rapid inhalation induction with sevoflurane.

Inhalation anesthetics enhance the potency of non-depolarizing muscle relaxants to a different degree. Sevoflurane appears to increase both intensity and duration of neuromuscular block induced by non-depolarizing muscle relaxants. However, Ahmed et al.6 reported that the maximum onset time produced by vecuronium was not shortened by an increase of sevoflurane exposure time under sevoflurane 2%. Lowry et al.7 reported that with 1.5 MAC sevoflurane the maximum onset time after administration of mivacurium did not differ from that during propofol infusion. Furthermore, Lowry et al.8 reported that intubating conditions after 0.6 mg•kg–1 rocuronium following anesthetic induction with a vital capacity induction technique with sevoflurane 8% in oxygen 100% or intravenous administration of 2-3 mg•kg–1 propofol were similar. They assessed intubating conditions one minute after intravenous rocuronium and patients received only two to three minutes of sevoflurane inhalation. In this study, we administered vecuronium intravenously three minutes after the start of anesthetic induction with sevoflurane, and the end-tidal concentration of sevoflurane was reached between 6 to 7% in the sevoflurane 8% group. Tracheal intubation could be performed approximately two minutes after administration of vecuronium. The time from the start of anesthesia to tracheal intubation in the present study was almost double that of Lowry et al.8 A longer duration of anesthetic induction with a high concentration of sevoflurane may induce easier intubating conditions. The speed of onset of paralysis after intravenous injection of a non-depolarizing muscle relaxant is related to age, circulation time, cardiac output and regional muscle blood flow.1216 A high concentration of volatile anesthetics may also be associated with the onset time of non-depolarizing muscle relaxants.

Anesthetic induction with sevoflurane 8% and maintenance with sevoflurane 2% induced the prolonged duration of action of vecuronium and a longer reversal time compared with intravenous anesthesia with propofol and fentanyl. However, there were no differences in recovery time or the reversal time between the propofol-sevoflurane group and the sevoflurane 8% group. This suggests that anesthetic induction with a high concentration of sevoflurane followed by maintenance of sevoflurane does not induce a longer duration of action of a non-depolarizing muscle relaxant and prolonged reversal time compared with a conventional technique using propofol and sevoflurane.

In conclusion, a vital capacity anesthetic induction technique with sevoflurane 8% may induce a more rapid onset time and may not prolong the duration of action of vecuronium compared with conventional techniques using propofol-sevoflurane anesthesia.

Accepted for publication October 9, 2000.


    References
 TOP
 Abstract
 Methods
 Results
 Discussion
 References
 
1 Hall JE, Stewart JIM, Harmer M. Single-breath inhalation induction of sevoflurane anaesthesia with and without nitrous oxide: a feasibility study in adults and comparison with an intravenous bolus of propofol. Anaesthesia 1997; 52: 410–5.[Medline]

2 Yurino M, Kimura H. A comparison of vital capacity breath and tidal breathing techniques for induction of anaesthesia with high sevoflurane concentrations in nitrous oxide and oxygen. Anaesthesia 1995; 50: 308–11.[Medline]

3 Hall JE, Oldham TA, Stewart JIM, Harmer M. Comparison between halothane and sevoflurane for adult vital capacity induction. Br J Anaesth 1997; 79: 285–8.[Abstract/Free Full Text]

4 Hall JE, Stewart JIM, Harmer M. Tachypnoea following vital capacity induction with sevoflurane (Letter). Anaesthesia 1996; 51: 890.[Medline]

5 Yurino M, Kimura H. Efficient inspired concentration of sevoflurane for vital capacity rapid inhalation induction (VCRII) technique. J Clin Anesth 1995; 7: 228–31.[Medline]

6 Ahmed AAK, Kumagai M, Otake T, Kurata Y, Amaki Y. Sevoflurane exposure time and the neuromuscular blocking effect of vecuronium. Can J Anesth 1999; 46: 429–32.[Abstract/Free Full Text]

7 Lowry DW, Mirakhur RK, McCarthy GJ, Carroll MT, McCourt KC. Neuromuscular effects of rocuronium during sevoflurane, isoflurane, and intravenous anesthesia. Anesth Analg 1998; 87: 936–40.[Abstract/Free Full Text]

8 Lowry DW, Mirakhur RK, Carroll MT, McCarthy GJ, Hughes DA, O'Hare RA. Potency and time course of mivacurium block during sevoflurane, isoflurane and intravenous anesthesia. Can J Anesth 1999; 46: 29–33.[Abstract/Free Full Text]

9 Yurino M, Kimura H. Vital capacity rapid inhalation induction technique: comparison of sevoflurane and halothane. Can J Anaesth 1993; 40: 440–3.

10 Sloan MH, Conard PF, Karsunky PK, Gross JB. Sevoflurane versus isoflurane: induction and recovery characteristics with single-breath inhaled inductions of anesthesia. Anesth Analg 1996; 82: 528–32.[Abstract]

11 Yurino M, Kimura H. Induction of anesthesia with sevoflurane, nitrous oxide, and oxygen: a comparison of spontaneous ventilation and vital capacity rapid inhalation induction (VCRII) techniques. Anesth Analg 1993; 76: 598–601.[Abstract/Free Full Text]

12 Fisher DM, O'Keeffe C, Stanski DR, Cronnelly R, Miller RD, Gregory GA. Pharmacokinetics and pharmacodynamics of d-tubocurarine in infants, children, and adults. Anesthesiology 1982; 57: 203–8.[Medline]

13 Fisher DM, Miller RD. Neuromuscular effects of vecuronium (ORG NC45) in infants and children during N2O, halothane anesthesia. Anesthesiology 1983; 58: 519–23.[Medline]

14 Kitajima T, Ishii K, Ogata H. Edrophonium as an antagonist of vecuronium-induced neuromuscular block in the elderly. Anaesthesia 1995; 50: 359–61.[Medline]

15 Upton RN, Huang YF. Influence of cardiac output, injection time and injection volume on the initial mixing of drugs with venous blood after i.v. bolus administration to sheep. Br J Anaesth 1993; 70: 333–8.[Abstract/Free Full Text]

16 Iwasaki H, Igarashi M, Yamauchi M, Namiki A. The effect of cardiac output on the onset of neuromuscular block by vecuronium. Anaesthesia 1995; 50: 361–2.[Medline]




This article has been cited by other articles:


Home page
Canadian J. AnesthesiaHome page
S. Yamaguchi, T. Ikeda, K. Wake, Y. Okuda, and T. Kitajima
A sevoflurane induction of anesthesia with gradual reduction of concentration is well tolerated in elderly patients: [L'induction de l'anesthesie au sevoflurane, avec une reduction graduelle de la concentration, est bien toleree par les patients ages]
Can J Anesth, January 1, 2003; 50(1): 26 - 31.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Résumé de cet Article
Right arrow Full Text (PDF)
Right arrow Submit a scholarly reply
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yamaguchi, S.
Right arrow Articles by Kitajima, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yamaguchi, S.
Right arrow Articles by Kitajima, T.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS